SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (212)11/17/1997 8:46:00 PM
From: John McCarthy   of 569
 
Wyeth-Ayerst Division

from CompuServe ... Reuters

Several analysts said a rumor had circulated widely along
Wall Street that Interneuron had failed to disclose Redux
had caused cardiac problems when tested in monkeys at a drug-
testing clinic in Scotland earlier this decade ....

The rumor is out there but its not true said Wyeth-Ayerst
spokesman Doug Petkus .....

Analysts disagree over effects ... but those in the negative
were more focused on the hold up of potential deals or
acqusitions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext